|
Video: What is a Stock Split?
|
|
Vaxart is a clinical-stage biotechnology company primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology proprietary oral vaccine platform. Co.'s oral vaccines are designed to generate immune responses that protect against a range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Co.'s investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. In addition, Co. is in early development of its first therapeutic vaccine targeting cervical cancer and dysplasia caused by human papillomavirus. According to our Vaxart stock split history records, Vaxart has had 1 split. | |
|
Vaxart (VXRT) has 1 split in our Vaxart stock split history database. The split for VXRT took place on February 14, 2018. This was a 1 for 11 reverse split, meaning for each 11 shares of VXRT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 90.9090909090909 share position following the split.
When a company such as Vaxart conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Vaxart stock split history from start to finish, an original position size of 1000 shares would have turned into 90.9090909090909 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vaxart shares, starting with a $10,000 purchase of VXRT, presented on a split-history-adjusted basis factoring in the complete Vaxart stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/06/2014 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$36.52 |
|
End price/share: |
$0.73 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.00% |
|
Average Annual Total Return: |
-32.38% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$199.87 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
02/14/2018 | 1 for 11 |
|
|